SCOPUS 정보 검색 플랫폼

Transplantation Proceedings

Volumn 45, Issue 5, 2013, Pages 1979-1980

MTOR inhibition in liver transplantation: How to dose for effective/safe CNI reduction?

(4) Junge, G a Dumortier, T a Schwende, H a Fung, J a

a Department of Integrated Hospital Care ^* (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EVEROLIMUS; TACROLIMUS;

ADULT; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG EXPOSURE; DRUG POTENCY; DRUG SAFETY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KIDNEY FUNCTION; LIVER BIOPSY; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UNSPECIFIED SIDE EFFECT;

HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; SIROLIMUS; TOR SERINE-THREONINE KINASES;

EID: 84879207839 PISSN: 00411345 EISSN: 18732623 Source Type: Journal
DOI: 10.1016/j.transproceed.2013.02.102 Document Type: Conference Paper

Times cited : (2)

References (4)

1
- 77957659746
- Everolimus: A proliferation signal inhibitor with clinical applications in organ transplantation, oncology, and cardiology
- S. Gabardi, S.A. Baroletti Everolimus: a proliferation signal inhibitor with clinical applications in organ transplantation, oncology, and cardiology Pharmacotherapy 10 2010 Oct 1044 1056
- (2010) Pharmacotherapy , vol.10 , pp. 1044-1056
- Gabardi, S.¹ Baroletti, S.A.²

2
- 84859317105
- Optimization of the use of Calcineurin inhibitors in liver transplantation
- E.L. de Mare-Bredemeijer, H.J. Metselaar Optimization of the use of Calcineurin inhibitors in liver transplantation Best Pract Res Clin Gastroenterol 26 1 2012 Feb 85 95
- (2012) Best Pract Res Clin Gastroenterol , vol.26 , Issue.1 , pp. 85-95
- De Mare-Bredemeijer, E.L.¹ Metselaar, H.J.²

3
- 70350563946
- Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: A prospective, randomized, multicenter trial
- P. De Simone, H.J. Metselaar, L. Fischer, J. Dumortier, K. Boudjema, J. Hardwigsen, L. Rostaing, L. De Carlis, F. Saliba, F. Nevens Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: a prospective, randomized, multicenter trial Liver Transpl 10 2009 Oct 1262 1269
- (2009) Liver Transpl , vol.10 , pp. 1262-1269
- De Simone, P.¹ Metselaar, H.J.² Fischer, L.³ Dumortier, J.⁴ Boudjema, K.⁵ Hardwigsen, J.⁶ Rostaing, L.⁷ De Carlis, L.⁸ Saliba, F.⁹ Nevens, F.¹⁰

4
- 84868208723
- Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: A randomized controlled trial
- H2304 Study Group
- P. De Simone, F. Nevens, L. De Carlis, H.J. Metselaar, S. Beckebaum, F. Saliba, S. Jonas, D. Sudan, J. Fung, L. Fischer, C. Duvoux, K.D. Chavin, B. Koneru, M.A. Huang, W.C. Chapman, D. Foltys, S. Witte, H. Jiang, J.M. Hexham, G. Junge H2304 Study Group Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial Am J Transplant 11 2012 Nov 3008 3020
- (2012) Am J Transplant , vol.11 , pp. 3008-3020
- De Simone, P.¹ Nevens, F.² De Carlis, L.³ Metselaar, H.J.⁴ Beckebaum, S.⁵ Saliba, F.⁶ Jonas, S.⁷ Sudan, D.⁸ Fung, J.⁹ Fischer, L.¹⁰ Duvoux, C.¹¹ Chavin, K.D.¹² Koneru, B.¹³ Huang, M.A.¹⁴ Chapman, W.C.¹⁵ Foltys, D.¹⁶ Witte, S.¹⁷ Jiang, H.¹⁸ Hexham, J.M.¹⁹ Junge, G.²⁰ more..

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.